-
Integrating sexual and reproductive health (SRH) into public health and primary care is one of those vexing problems: complex, multifaceted, and requiring disparate groups to work together to develop strategies and policy activities that align pre-licensure SRH education, continuing professional development, and service delivery for all healthcare professionals within an integrated primary healthcare framework.
-
-
Increasing the capacity of U.S. clinicians to provide high quality sexual and reproductive health (SRH) care for all Americans is an urgent public health priority, and proponents are working fast to implement new strategies to meet the need.
-
An experimental levonorgestrel 20 mcg intrauterine device (LNG20 IUD) is under development by Medicines360, a San Francisco-based nonprofit pharmaceutical company.
-
This new evidence-based guidance from the CDC will improve and streamline how we provide contraceptive services to our patients, says Andrew Kaunitz, MD
-
In a large population of Caucasian women participating in the Womens Health Initiative Observational Study, those who used aspirin had a significantly lower risk of melanoma and increased duration of use was associated with incrementally greater protection.
-
The FDA has approved paroxetine for the treatment of hot flashes (vasomotor symptoms) in postmenopausal women.
-
How do we involve patients in decisions about their health care? This study from the Informed Medical Decisions Foundation attempts to answer the question using the results of a survey conducted between 2010 and 2011 with a probability sample from across the United States.
-
-
A case-control study of women in the Nurses Health Study Cohort showed that lower melatonin secretion is independently associated with a higher risk of developing type 2 diabetes. There is a physiologic basis for this finding since melatonin has a role in glucose metabolism and lack of melatonin is associated with increased insulin resistance.